Build together
QA and complete the existing OrkastraRX pilot on Dynamics 365 Sales; validate its proposed OneScan integration.
Agilidy / LSPedia · Proposed partnership POV
I already have a working OrkastraRX pilot on Dynamics 365 Sales, built with guidance from a pharmaceutical executive with 30+ years of experience. I propose partnering with LSPedia to QA and validate it, build OneScan and Dynamics 365 Supply Chain Management integrations, publish through Microsoft Marketplace, and pursue a joint Microsoft co-sell motion—led fractionally as LSPedia expands its sales team.
Prepared by Jason Wickman · Founder, Agilidy · October 2026 · Independent strategic perspective
Why now · Competitive market opportunity
Veeva is transitioning customers from its legacy Salesforce-based CRM to Vault CRM, with legacy support scheduled to end December 31, 2029. Salesforce Life Sciences Cloud is another competitor. This creates a window to propose a Microsoft-based specialty pharma option—not a guaranteed migration opportunity.
QA and complete the existing OrkastraRX pilot on Dynamics 365 Sales; validate its proposed OneScan integration.
Connect commercial orchestration and traceability; explore Dynamics 365 Supply Chain Management opportunities.
Pursue joint Microsoft sales plays for OneScan, OrkastraRX and applicable Dynamics 365 solutions, subject to eligibility.
As LSPedia hires account executives, Jason proposes to help fractionally complete the solution, develop the Microsoft alliance and create shared pipeline. This is a partnership proposal, not a full-time job application.
Proposed competitive positioning; no claim of a completed Veeva replacement or approved Microsoft co-sell arrangement.
The partnership proposal · Build together. Co-sell together.
This is not a request for LSPedia to become an OrkastraRX customer or a referral partner. It is a proposal for LSPedia and Agilidy to jointly develop an integrated offering, then pursue qualified opportunities for both OneScan and OrkastraRX alongside Microsoft sellers and the Microsoft partner ecosystem.
01 · Build
LSPedia contributes OneScan and pharmaceutical traceability expertise. Agilidy contributes OrkastraRX, Dynamics 365 architecture and implementation experience. Jointly validate an integration and package the customer value proposition.
02 · Position
Jason Wickman brings experience helping launch Microsoft CRM, serving as a Microsoft Dynamics Sales Director, and working at the intersection of sales, marketing, service and technology. Use that background to shape a credible joint Dynamics 365 and specialty pharma proposition.
03 · Co-sell
Develop joint sales plays, customer targeting and Microsoft-facing solution collateral; evaluate Microsoft Marketplace listings and Partner Center co-sell pathways for each eligible offer. Share opportunities through a mutually agreed partner-led sales motion.
The intended outcome: a repeatable joint solution and shared pipeline for both partners.
This is a proposed partnership, not an existing LSPedia–Agilidy–Microsoft arrangement. LSPedia's current Microsoft co-sell participation has not been confirmed. Marketplace and co-sell status require offer-specific qualification and Microsoft review; neither Microsoft participation nor seller support is guaranteed.
Microsoft's current co-sell eligibility requirements ↗The thesis
LSPedia OneScan already handles the hardest back-office problems in pharma: serialization, traceability, supply chain integrity and regulatory compliance. Those capabilities are not in question.
The open question is commercial: how do specialty pharma teams plan launches, manage contract pharmacy and HCP accounts, and coordinate field activity on top of that compliant foundation? Today that work often lives in spreadsheets, point tools or a generic CRM that was not built for specialty pharma workflows.
OrkastraRX already has a working pilot on Dynamics 365 Sales, built with guidance from a pharmaceutical executive with over 30 years of experience. The proposal is to partner with LSPedia to QA, validate, integrate, publish and co-sell it.
Inside OrkastraRX · Platform concepts
Adapted from the OrkastraRX strategic presentation. These are conceptual product visuals, not live customer dashboards, measured results, or evidence of a completed OneScan integration.
Platform architecture · OrkastraRX deck, slide 5
ORKASTRARX CORE ENGINE
Unified intelligence · prediction · orchestration
Proposed LSPedia opportunity: assess which OneScan events can safely and usefully enrich this intelligence layer.
Revenue Leakage Funnel™ · deck slide 3
Illustrative funnel shape adapted from the deck; not LSPedia or customer performance data.
Launch Mission Engine™ · deck slide 8
Activate Tampa Nephrology
WHY NOW
High patient potential + payer policy change
HIDDEN BLOCKER
Prior auth burden on office staff
BEST ANGLE
Workflow simplification + onboarding kit
SUCCESS CRITERIA
2 patient candidates + scheduled next meeting
Illustrative mission example from the OrkastraRX presentation.
Source: OrkastraRX strategic deck supplied for this discussion, slides 3, 5 and 8. The original deck also illustrates the Physician Access Graph™ (slide 7) and Launch Command Center (slide 10).
Proposed architecture
The diagram below is a proposed reference architecture. No integration between OrkastraRX and OneScan has been built or certified. It is a starting point for a joint validation, not a deployed system.
Front office · proposed
Sales, account management and specialty pharma launch workflows.
Back office · verified platform
Serialization, supply chain and compliance (per lspedia.com).
Integration layer · proposed, not built
A proposed, bounded data flow that surfaces OneScan serialization, shipment and exception events into Dynamics 365 account and launch records, and routes commercial decisions back as context. Everything in this band is a hypothesis to validate, not a shipped connector.
Launch readiness signals
OneScan serialization status → D365 launch milestone
Account compliance view
Read-only shipment and exception status per account
Exception routing
OneScan exceptions → responsible account owner in D365
Commercial value
Launch account targeting, field coordination and milestone tracking in one commercial system, with OneScan serialization readiness visible alongside.
A single account record across contract pharmacies, HCP networks and health systems, with proposed read-only compliance context from OneScan.
Serialization exceptions and recalls routed to the responsible account owner, so commercial outreach and substitution decisions happen sooner.
Value statements are hypotheses to validate during the pilot-to-market roadmap, not measured customer outcomes or guaranteed benefits.
Three practical use cases
A specialty product launch touches contract pharmacies, limited distribution networks, REMS programs and payer access. A proposed OrkastraRX layer on Dynamics 365 would let commercial teams plan account targeting, track launch milestones and coordinate field engagement, while OneScan manages the serialization, GTIN allocation and compliant distribution underneath.
Proposed capabilities to validate
Specialty distribution relationships span multiple contract pharmacy partners, health systems and HCP practices. A proposed front-office account model would consolidate contract terms, service-level commitments and interaction history, while OneScan continues to own the verified product movement and compliance records behind each account.
Proposed capabilities to validate
When a serialization exception, supply disruption or recall occurs, commercial teams need to know which accounts and patients are affected. A proposed integration would surface OneScan traceability data to sales and account leadership so outreach, substitution and continuity decisions happen faster.
Proposed capabilities to validate
Proposed pilot-to-market roadmap
Five jointly governed stages from an existing pilot to a validated commercial offer. Timeline, responsibilities, quality gates and ownership would be agreed with LSPedia.
01 · Existing pilot
02 · QA and pharma validation
03 · Integrate
04 · Marketplace
05 · Co-sell
Timeline is a proposed plan for discussion, not a committed schedule or guaranteed outcome. Actual durations depend on scope, data access, security review and joint resourcing.
What is verified vs. what is proposed
Partnership discussion
If the architecture and use cases here are worth validating, the next step is a short working session to review the existing pilot, agree QA and pharmaceutical validation gates, scope OneScan and Supply Chain integrations, and align on Marketplace and co-sell responsibilities.
No LSPedia, OrkastraRX or Microsoft endorsement, partnership or commercial relationship is implied by this page. All integrations are proposed and require joint validation.